Silo Pharma Announces $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules Nanotech Investing
Nuvation Bio Enrolls First Patient in TRUST-IV Phase 3 Study of IBTROZI for the Adjuvant Treatment of ROS1-Positive Early-Stage Non-Small Cell Lung Cancer Nanotech Investing
Qualigen Therapeutics Announces Successful Closing of $41 Million PIPE Financing Led by Faraday Future, Accelerating New Business Transformation into Crypto Nanotech Investing
OHA is Administrative Agent & Lead Left Arranger of Private Unitranche Financing Supporting Francisco Partners' Acquisition of Elite Fintech Investing
Faraday Future Announces Closing of Strategic $41 Million Investment in Qualigen Therapeutics to Accelerate its Dual-Flywheel & Dual-Bridge Eco Strategy Nanotech Investing
Edgewater Wireless Reports First Quarter Fiscal 2027 Results and Advances PrismIQ Commercialization Roadmap
Syntholene Engages Imperial College of London Expert for Independent Technical Review of Operating Data from Iceland Demonstration Facility
